6,544 followers
New research: Cost-Effectiveness of Ipilimumab Plus Anti-PD-1 Therapy Versus Ipilimumab Alone in Patients With Metastatic Melanoma Resistant to Anti-PD-(L)1 Monotherapy: Objective The use of ipilimumab plus anti-PD-1 has recently been shown to… https://t.c